NFKB1 and colitis: In summary, our work revealed that the knockout of GPR174 could reduce intestinal inflammation and repair the epithelium barrier by suppressing DCs maturation and naïve T cell differentiation to alleviate DSS-induced colitis, which was probably through inhibiting the TNF-α (NF-κB) pathway.